Ultra-Expensive Drugs And Medicare Part D: Spending And Beneficiary Use Up Sharply.

Health Affairs
So-Yeon KangGerard F Anderson

Abstract

The proliferation of "ultra-expensive" drugs has sparked debate on their sustainability and affordability. Medicare Part D's share of annual spending on these drugs increased by 1,170 percent between 2012 and 2018, largely because the number of beneficiaries receiving them increased during this period.

References

Sep 5, 2013·Cancer·Donald W Light, Hagop Kantarjian
May 7, 2014·JAMA Internal Medicine·Robert Steinbrook, Rita F Redberg
May 5, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ya-Chen Tina ShihFabrice Smieliauskas
Jul 25, 2018·Lancet·Lucio LuzzattoUNKNOWN Second Workshop on Orphan Drugs participants
May 29, 2019·JAMA : the Journal of the American Medical Association·Stacie B DusetzinaNancy L Keating
Oct 3, 2019·The New England Journal of Medicine·Tara Sklar, Christopher Robertson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Michael J DiStefanoGerard F Anderson
Health Affairs
Dale N Schumacher, Eric D Dobkin
© 2021 Meta ULC. All rights reserved